TP53 and Patent ductus arteriosus: Once received by neighboring PDA tumor cells, miR-155 protected receiving-PDA cells from gemcitabine-induced cell death by impairing the activation of pro-apoptotic stress-induced p53 target gene TP31INP1 [51].